How little we know: The search for a simple answer on acute beta-blocker use in the management of acute coronary syndrome

Academic Emergency Medicine

Volumn 17, Issue 1, 2010, Pages 93-95

  Miller, Chadwick D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ACUTE CORONARY SYNDROME; CLINICAL TRIAL; EMERGENCY MEDICINE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; ST SEGMENT ELEVATION; THORAX PAIN; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 75449117926     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00629.x     Document Type: Note

References (13)

1. Brandler E, Paladino L, Sinert R. Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome? Acad Emerg Med. 2009; 17: 1-10.
2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology ? American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non STElevation Myocardial Infarction). Circulation. 2007; 116803-77.
3. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC?AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology ? American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC?AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008; 117:296-329.
4. Al-Reesi A, Al-Zadjali N, Perry J, et al. Do betablockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis. Can J Emerg Med. 2008; 10:215-23.
5. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebocontrolled trial. Lancet. 2005; 366:1622-32.
6. Sabatine MS. Something old, something new: beta blockers and clopidogrel in acute myocardial infarction. Lancet. 2005; 366:1587-9.
7. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985; 27:335-71.
8. Norris RM, Clarke ED, Sammel NL, Smith WM, Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978; 2:907-9.
9. Yusuf S, Sleight P, Rossi P, et al. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation. 1983; 67:I32-41.
10. Ibanez B, Prat-Gonzalez S, Speidl WS, et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007; 115:2909-16.
11. Pettersen K, Kvan E, Rollag A, Stavem K, Reikvam A. Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction. BMC Cardiovasc Disord. 2008; 8:28.
12. Ecochard R, Colin C, Rabilloud M, et al. Indicators of myocardial dysfunction and quality of life, one year after acute infarction. Eur J Heart Fail. 2001; 3:561-8.
13. Miller CD, Roe MT, Mulgund J, et al. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med. 2007; 120:685-92.